[Prevention of tetanus in man and animal following injury].
Abstract: The effect of heterologous and homologous antitoxin is the same if an equal amount of antitoxin is present in the organism. In man there are no circulating antibodies in the blood after the first injection of the toxoid because there is no natural immunity against the tetanus antigen. After the second injection, man develops the same immunity as animals. Large antitoxin doses protect people for a longer period than small doses. Normally 3,000 I. U. of the heterologous antitoxin protects people for 2 to 3 weeks. In man and sheep 2 ml of the adsorbed vaccine produces an earlier and longer-lasting immunity than 0.5 ml. Simultaneous active and passive prophylaxis is superior to passive prophylaxis alone. To achieve a long-lasting active immunity, 2 ml of the vaccine should first be injected and a booster dose 7 to 10 days later, and again 6 to 12 weeks after the first dose. Immediate vaccination against tetanus following an injury will not protect a person who has not been vaccinated previously, as the active immunity will start too late.
Publication Date: 1975-06-01 PubMed ID: 1190969
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- English Abstract
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The researchers investigated methods to prevent tetanus from developing in both humans and animals following an injury. They discovered that large doses of antitoxin provided extended protection and that effective, long-term immunity required multiple vaccinations, including an initial dose and two follow-ups. Immediate vaccination post-injury was not effective in individuals who hadn’t been previously vaccinated.
Antitoxin Effectiveness
- The paper begins by discussing the effectiveness of heterologous and homologous antitoxin. The researchers found that their ability to stop tetanus toxin from affecting the body is about the same if equal amounts of both are present.
- However, the study reveals a key difference in the initial reaction of humans to the injected toxoid – humans, unlike some animals, don’t have any natural immunity to the tetanus antigen, meaning there are no circulating antibodies in the blood after the first injection.
- After a second injection, humans develop a similar level of immunity to that of animals.
Dosage and Duration of Protection
- The paper goes on to detail how the size of the antitoxin dose affects its protective duration. Larger doses of antitoxin provide longer-lasting protection against tetanus compared to smaller doses.
- As an estimated guideline, the researchers note that generally around 3,000 I.U. of heterologous antitoxin is predicted to protect individuals for 2 to 3 weeks.
Active and Passive Prophylaxis
- The researchers discuss the combination of active and passive prophylaxis. Simultaneous active and passive prophylaxis, which involves using a vaccine to stimulate the immune system while also providing direct disease-fighting molecules, is identified as superior to relying on passive prophylaxis alone.
- To achieve a long-lasting active immunity, they suggest a vaccination regimen that includes an initial injection of 2 ml of the vaccine, a booster dose 7 to 10 days afterward, and a final dose 6 to 12 weeks after the first.
Vaccination Timing
- The paper concludes by discussing the timing of vaccination in the event of injury. Due to the delay in the onset of active immunity, an immediate post-injury vaccination will not protect an individual who has not previously been vaccinated against tetanus.
Cite This Article
APA
Radvila P.
(1975).
[Prevention of tetanus in man and animal following injury].
Arch Exp Veterinarmed, 29(3), 469-481.
Publication
Researcher Affiliations
MeSH Terms
- Animals
- Guinea Pigs
- Horse Diseases / prevention & control
- Horses
- Humans
- Immunity, Active
- Immunity, Maternally-Acquired
- Immunotherapy
- Rabbits
- Tetanus / drug therapy
- Tetanus / etiology
- Tetanus / prevention & control
- Tetanus / veterinary
- Tetanus Antitoxin / pharmacology
- Tetanus Toxin / pharmacology
- Vaccination
- Wounds and Injuries / complications
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists